Concomitant experimental coinfection by Plasmodium berghei NK65-NY and Ascaris suum downregulates the Ascaris-specific immune response and potentiates Ascaris-associated lung pathology.
Ascaris suum
Coinfection
Helminth infection
Lung inflammation
Lung injury
Malaria
Plasmodium berghei NK65-NY
Pulmonary mechanics
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
01 Jul 2021
01 Jul 2021
Historique:
received:
01
10
2020
accepted:
17
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
14
10
2021
Statut:
epublish
Résumé
Ascariasis and malaria are highly prevalent parasitic diseases in tropical regions and often have overlapping endemic areas, contributing to high morbidity and mortality rates in areas with poor sanitary conditions. Several studies have previously aimed to correlate the effects of Ascaris-Plasmodium coinfections but have obtained contradictory and inconclusive results. Therefore, the present study aimed to investigate parasitological and immunopathological aspects of the lung during murine experimental concomitant coinfection by Plasmodium berghei and Ascaris suum during larvae ascariasis. C57BL/6J mice were inoculated with 1 × 10 Animals coinfected with P. berghei and A. suum show decreased production of type 1, 2, and 17 and regulatory cytokines; low leukocyte recruitment in the tissue; increased cellularity in the circulation; and low levels of NAG, MPO and EPO activity that lead to an increase in larvae migration, as shown by the decrease in larvae recovered in the lung parenchyma and increase in larvae recovered in the airway. This situation leads to severe airway haemorrhage and, consequently, an impairment respiratory function that leads to high morbidity and early mortality. This study demonstrates that the Ascaris-Plasmodium interaction is harmful to the host and suggests that this coinfection may potentiate Ascaris-associated pathology by dampening the Ascaris-specific immune response, resulting in the early death of affected animals.
Sections du résumé
BACKGROUND
BACKGROUND
Ascariasis and malaria are highly prevalent parasitic diseases in tropical regions and often have overlapping endemic areas, contributing to high morbidity and mortality rates in areas with poor sanitary conditions. Several studies have previously aimed to correlate the effects of Ascaris-Plasmodium coinfections but have obtained contradictory and inconclusive results. Therefore, the present study aimed to investigate parasitological and immunopathological aspects of the lung during murine experimental concomitant coinfection by Plasmodium berghei and Ascaris suum during larvae ascariasis.
METHODS
METHODS
C57BL/6J mice were inoculated with 1 × 10
RESULTS
RESULTS
Animals coinfected with P. berghei and A. suum show decreased production of type 1, 2, and 17 and regulatory cytokines; low leukocyte recruitment in the tissue; increased cellularity in the circulation; and low levels of NAG, MPO and EPO activity that lead to an increase in larvae migration, as shown by the decrease in larvae recovered in the lung parenchyma and increase in larvae recovered in the airway. This situation leads to severe airway haemorrhage and, consequently, an impairment respiratory function that leads to high morbidity and early mortality.
CONCLUSIONS
CONCLUSIONS
This study demonstrates that the Ascaris-Plasmodium interaction is harmful to the host and suggests that this coinfection may potentiate Ascaris-associated pathology by dampening the Ascaris-specific immune response, resulting in the early death of affected animals.
Identifiants
pubmed: 34210332
doi: 10.1186/s12936-021-03824-w
pii: 10.1186/s12936-021-03824-w
pmc: PMC8248286
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
296Subventions
Organisme : FAPEMIG
ID : CBB APQ-00766-18
Organisme : CNPq
ID : 421392/2018-5
Organisme : CNPq
ID : 302491/2017-1
Références
Am J Respir Crit Care Med. 2007 Sep 15;176(6):556-64
pubmed: 17600276
Am J Respir Cell Mol Biol. 2013 May;48(5):589-600
pubmed: 23328641
Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1385-94
pubmed: 9355131
Exp Parasitol. 1984 Feb;57(1):20-4
pubmed: 6363116
Front Immunol. 2016 Nov 07;7:463
pubmed: 27872623
Lancet. 2018 Apr 21;391(10130):1608-1621
pubmed: 29631781
Ann Trop Med Parasitol. 2006 Oct;100(7):551-70
pubmed: 16989681
Blood. 2011 Sep 1;118(9):2578-88
pubmed: 21725055
J Infect Dis. 2000 Oct;182(4):1207-13
pubmed: 10979919
PLoS Negl Trop Dis. 2019 Nov 25;13(11):e0007896
pubmed: 31765381
Nat Rev Dis Primers. 2017 Aug 03;3:17050
pubmed: 28770814
Pathog Dis. 2013 Nov;69(2):127-41
pubmed: 23929557
J Biomed Biotechnol. 2011;2011:821578
pubmed: 22219659
Parasite Immunol. 2015 Jun;37(6):304-13
pubmed: 25869527
Nat Rev Immunol. 2007 Dec;7(12):975-87
pubmed: 18007680
Int J Biol Sci. 2012;8(9):1281-90
pubmed: 23136556
Trends Parasitol. 2013 Jul;29(7):346-58
pubmed: 23742967
Parasitology. 2006 Feb;132(Pt 2):289-300
pubmed: 16209722
Parasite Immunol. 2002 Nov-Dec;24(11-12):499-509
pubmed: 12694600
Trends Parasitol. 2017 Sep;33(9):678-693
pubmed: 28566191
Parasite Immunol. 2007 Jul;29(7):347-58
pubmed: 17576364
Parasite Immunol. 2006 Sep;28(9):453-61
pubmed: 16916369
Annu Rev Immunol. 2005;23:69-99
pubmed: 15771566
Nat Immunol. 2013 Nov;14(11):1118-1126
pubmed: 24145791
Biomed Res Int. 2016;2016:3083568
pubmed: 27092310
Int J Parasitol. 2011 Aug 15;41(10):1041-51
pubmed: 21777589
Malar J. 2011 Sep 12;10:259
pubmed: 21910854
Ecol Lett. 2015 Dec;18(12):1387-96
pubmed: 26477454
Parasitology. 1995 Sep;111 ( Pt 3):385-93
pubmed: 7567106
Trends Parasitol. 2018 May;34(5):388-403
pubmed: 29339033
Ann Med. 2007;39(6):428-39
pubmed: 17852030
J Leukoc Biol. 2005 Aug;78(2):352-8
pubmed: 15894588
PLoS One. 2015 Dec 01;10(12):e0143195
pubmed: 26624290
Parasitology. 2007 Aug;134(Pt 9):1301-14
pubmed: 17381887
Cell Microbiol. 2012 Mar;14(3):343-55
pubmed: 22188297
J Immunol. 2009 May 1;182(9):5663-71
pubmed: 19380813
Front Immunol. 2018 Nov 09;9:2535
pubmed: 30473693
PLoS Negl Trop Dis. 2016 Jan 27;10(1):e0004382
pubmed: 26814713
Lancet. 2006 May 6;367(9521):1521-32
pubmed: 16679166
Parasit Vectors. 2014 Jan 21;7:37
pubmed: 24447578
Vaccine. 2011 Dec 30;29 Suppl 4:D104-10
pubmed: 22188933
Immunol Rev. 2011 Jul;242(1):161-77
pubmed: 21682744
PLoS Negl Trop Dis. 2018 Jan 26;12(1):e0006197
pubmed: 29373600
J Allergy Clin Immunol. 2016 Sep;138(3):666-675
pubmed: 27476889
J Clin Invest. 1992 May;89(5):1403-10
pubmed: 1569183
Annu Rev Pathol. 2011;6:147-63
pubmed: 20936936
PLoS Pathog. 2012 Feb;8(2):e1002401
pubmed: 22319438
Malar J. 2014 Mar 26;13:116
pubmed: 24670210
J Parasitol. 1998 Feb;84(1):16-8
pubmed: 9488331
Int J Parasitol. 2010 Aug 15;40(10):1137-44
pubmed: 20430032
J Clin Invest. 2019 Aug 5;129(9):3686-3701
pubmed: 31380805
Parasite Immunol. 2006 Oct;28(10):497-506
pubmed: 16965285
Chest. 2012 Aug;142(2):492-505
pubmed: 22871759
PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2865
pubmed: 25058013
Wien Klin Wochenschr. 2010 Oct;122 Suppl 3:94-6
pubmed: 20924692
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
Trends Immunol. 2016 Sep;37(9):597-607
pubmed: 27501916
Parasite Immunol. 2004 Nov-Dec;26(11-12):429-41
pubmed: 15771679
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):88-98
pubmed: 18165479
Acta Trop. 2011 Oct-Nov;120(1-2):31-9
pubmed: 21722620
Microbes Infect. 2011 Jul;13(7):632-7
pubmed: 20934531
PLoS Negl Trop Dis. 2018 Sep 20;12(9):e0006711
pubmed: 30235205
J Immunol. 2002 Sep 15;169(6):2956-63
pubmed: 12218109
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:52-63
pubmed: 21881757
Int J Parasitol. 2013 Aug;43(9):697-706
pubmed: 23665127
Int J Parasitol. 2017 Jan;47(1):1-10
pubmed: 28003150
Semin Respir Crit Care Med. 2006 Apr;27(2):171-84
pubmed: 16612768
J Infect Dis. 1998 Oct;178(4):1133-8
pubmed: 9806045
J Infect Dis. 1996 Jan;173(1):269-72
pubmed: 8537675
Parasitol Res. 1988;74(6):544-51
pubmed: 3143108
Cytometry A. 2010 Jun;77(6):515-23
pubmed: 20191617
PLoS Negl Trop Dis. 2009 Aug 25;3(8):e412
pubmed: 19707588